(Reuters) - Regeneron Pharmaceuticals said on Monday its experimental gene therapy showed improved hearing in 10 of 11 children between 10 months and 16 years old born with hearing loss caused by ...

Congenital cytomegalovirus (CMV) infection is a leading cause of sensorineural hearing loss (SNHL) in children. Whether connexin mutations are factors in the development of CMV-related hearing ...

Hearing impairment affects millions globally, with genetics playing a major role in infant hearing loss. Early screening and genetic testing are cruci ...

Congenital hearing loss is the most common sensory deficit in children worldwide and can cause significant challenges in early childhood development. The Council aims to address these challenges ...

As part of the Rashtriya Bal Swasthya Karyakram (RBSK), the District Early Intervention Centre (DEIC) at the Government ...

Noise-induced hearing loss (NIHL) is different from age-related hearing loss which mostly happens when the loud noises tend ...

Between March 2003 and May 2009, 121 infants with congenital CMV infection ... performed on different occasions. A child was considered to have normal hearing when the first ABR threshold was ...

today announced updated data for the investigational gene therapy DB-OTO from the Phase 1/2 CHORD trial in 12 children who have profound genetic hearing loss due to variants of the otoferlin (OTOF ...

Lilly makes waves, says gene therapy restores hearing for child with genetic hearing loss When asked how DB ... “Intervention with congenital deafness is urgent, so we try to provide ...

CMV is a virus that can be transmitted from a pregnant mother to her child and often results in hearing loss, vision problems ... in 200 babies are born with congenital CMV, and one in five ...

"This consortium, composed of leading stakeholders, is currently one of the few players worldwide capable of bringing about a technological and medical revolution that offers real hope for all ...